Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileJoel Stephen Finkelstein, M.D.

TitleProfessor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
Endocrine, Thier 1051
55 Fruit St
Boston MA 02114
Phone617/726-3296
Fax617/726-1703
vCardDownload vCard (login for email)

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R01AG030545     (FINKELSTEIN, JOEL S)Sep 15, 2007 - Nov 30, 2012
NIH/NIA
Physiologic effects of androgen and estrogen deficiency in young and old men
Role: Principal Investigator

S10RR023405     (FINKELSTEIN, JOEL S)Jun 1, 2007 - May 31, 2008
NIH/NCRR
X-Treme CT Equipment Grant
Role: Principal Investigator

K24DK002759     (FINKELSTEIN, JOEL S)Sep 1, 1999 - Jul 31, 2009
NIH/NIDDK
Effects of androgens, estrogens, and PTH on bone
Role: Principal Investigator

P50AR044855     (KRONENBERG, HENRY M)Sep 22, 1997 - Aug 31, 2008
NIH/NIAMS
Specialized Center for Research in Osteoporosis
Role: Co-Principal Investigator

U01AG012531     (FINKELSTEIN, JOEL S)Sep 30, 1994 - Jun 30, 2019
NIH/NIA
Study of Women's Health Across the Nation - V
Role: Principal Investigator
Collapse research resources
This researcher has shared information about their research resources
in the eagle-i Network. To update or add resource records, contact
eagle-i@hms.harvard.edu.

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, Engelke K, Finkelstein JS, Genant HK, Goemaere S, Hyldstrup L, Jodar-Gimeno E, Keaveny TM, Kendler D, Lakatos P, Maddox J, Malouf J, Massari FE, Molina JF, Ulla MR, Grauer A. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet. 2017 Sep 30; 390(10102):1585-1594. PMID: 28755782.
    View in: PubMed
  2. Santoro N, Crawford SL, El Khoudary SR, Allshouse AA, Burnett-Bowie SA, Finkelstein J, Derby C, Matthews K, Kravitz HM, Harlow SD, Greendale GA, Gold EB, Kazlauskaite R, McConnell D, Neal-Perry G, Pavlovic J, Randolph J, Weiss G, Chen HY, Lasley B. Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2017 Jul 01; 102(7):2218-2229. PMID: 28368525.
    View in: PubMed
  3. Ercan A, Kohrt WM, Cui J, Deane KD, Pezer M, Yu EW, Hausmann JS, Campbell H, Kaiser UB, Rudd PM, Lauc G, Wilson JF, Finkelstein JS, Nigrovic PA. Estrogens regulate glycosylation of IgG in women and men. JCI Insight. 2017 Feb 23; 2(4):e89703. PMID: 28239652.
    View in: PubMed
  4. Putman MS, Yu EW, Lin D, Darakananda K, Finkelstein JS, Bouxsein ML. Differences in Trabecular Microstructure Between Black and White Women Assessed by Individual Trabecular Segmentation Analysis of HR-pQCT Images. J Bone Miner Res. 2017 May; 32(5):1100-1108. PMID: 27958659.
    View in: PubMed
  5. Lee YC, Karlamangla AS, Yu Z, Liu CC, Finkelstein JS, Greendale GA, Harlow SD, Solomon DH. Pain Severity in Relation to the Final Menstrual Period in a Prospective Multiethnic Observational Cohort: Results From the Study of Women's Health Across the Nation. J Pain. 2017 Feb; 18(2):178-187. PMID: 27836812.
    View in: PubMed
  6. Pastore LM, Young SL, Manichaikul A, Baker VL, Wang XQ, Finkelstein JS. Distribution of the FMR1 gene in females by race/ethnicity: women with diminished ovarian reserve versus women with normal fertility (SWAN study). Fertil Steril. 2017 Jan; 107(1):205-211.e1. PMID: 27816231.
    View in: PubMed
  7. Taylor AP, Lee H, Webb ML, Joffe H, Finkelstein JS. Effects of Testosterone and Estradiol Deficiency on Vasomotor Symptoms in Hypogonadal Men. J Clin Endocrinol Metab. 2016 Sep; 101(9):3479-86. PMID: 27300575; PMCID: PMC5010571 [Available on 09/01/17].
  8. Shanbhogue VV, Finkelstein JS, Bouxsein ML, Yu EW. Association Between Insulin Resistance and Bone Structure in Nondiabetic Postmenopausal Women. J Clin Endocrinol Metab. 2016 Aug; 101(8):3114-22. PMID: 27243136; PMCID: PMC4971339 [Available on 08/01/17].
  9. Solomon DH, Ruppert K, Greendale GA, Lian Y, Selzer F, Finkelstein JS. Medication Use by Race and Ethnicity in Women Transitioning Through the Menopause: A Study of Women's Health Across the Nation Drug Epidemiology Study. J Womens Health (Larchmt). 2016 Jun; 25(6):599-605. PMID: 27028503; PMCID: PMC4900213 [Available on 06/01/17].
  10. Putman MS, Greenblatt LB, Sicilian L, Uluer A, Lapey A, Sawicki G, Gordon CM, Bouxsein ML, Finkelstein JS. Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis. Osteoporos Int. 2016 Aug; 27(8):2497-505. PMID: 26952010; PMCID: PMC4947435 [Available on 08/01/17].
  11. Finkelstein JS, Lee H, Leder BZ, Burnett-Bowie SA, Goldstein DW, Hahn CW, Hirsch SC, Linker A, Perros N, Servais AB, Taylor AP, Webb ML, Youngner JM, Yu EW. Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest. 2016 Mar 01; 126(3):1114-25. PMID: 26901812; PMCID: PMC4767351.
  12. Pastore LM, Manichaikul A, Wang XQ, Finkelstein JS. FMR1 CGG Repeats: Reference Levels and Race-Ethnic Variation in Women With Normal Fertility (Study of Women's Health Across the Nation). Reprod Sci. 2016 Sep; 23(9):1225-33. PMID: 26905421.
    View in: PubMed
  13. Baker JF, Putman MS, Herlyn K, Tillotson AP, Finkelstein JS, Merkel PA. Body composition, lung function, and prevalent and progressive bone deficits among adults with cystic fibrosis. Joint Bone Spine. 2016 Mar; 83(2):207-11. PMID: 26677995.
    View in: PubMed
  14. Fehlings MG, Nater A, Tetreault L, Kopjar B, Arnold P, Dekutoski M, Finkelstein J, Fisher C, France J, Gokaslan Z, Massicotte E, Rhines L, Rose P, Sahgal A, Schuster J, Vaccaro A. Survival and Clinical Outcomes in Surgically Treated Patients With Metastatic Epidural Spinal Cord Compression: Results of the Prospective Multicenter AOSpine Study. J Clin Oncol. 2016 Jan 20; 34(3):268-76. PMID: 26598751.
    View in: PubMed
  15. Solomon DH, Ruppert K, Zhao Z, Lian YJ, Kuo IH, Greendale GA, Finkelstein JS. Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study. Osteoporos Int. 2016 Mar; 27(3):1181-1189. PMID: 26449354; PMCID: PMC4813302.
  16. Mitchell DM, Leder BZ, Cagliero E, Mendoza N, Henao MP, Hayden DL, Finkelstein JS, Burnett-Bowie SA. Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial. Am J Clin Nutr. 2015 Aug; 102(2):385-92. PMID: 26156733; PMCID: PMC4515870 [Available on 08/01/16].
  17. Ahn H, Bailey CS, Rivers CS, Noonan VK, Tsai EC, Fourney DR, Attabib N, Kwon BK, Christie SD, Fehlings MG, Finkelstein J, Hurlbert RJ, Townson A, Parent S, Drew B, Chen J, Dvorak MF. Effect of older age on treatment decisions and outcomes among patients with traumatic spinal cord injury. CMAJ. 2015 Sep 08; 187(12):873-80. PMID: 26149702; PMCID: PMC4562825.
  18. Cauley JA, Greendale GA, Ruppert K, Lian Y, Randolph JF, Lo JC, Burnett-Bowie SA, Finkelstein JS. Serum 25 hydroxyvitamin D, bone mineral density and fracture risk across the menopause. J Clin Endocrinol Metab. 2015 May; 100(5):2046-54. PMID: 25719933; PMCID: PMC4422899.
  19. Putman MS, Baker JF, Uluer A, Herlyn K, Lapey A, Sicilian L, Tillotson AP, Gordon CM, Merkel PA, Finkelstein JS. Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period. J Cyst Fibros. 2015 Jul; 14(4):526-32. PMID: 25698451; PMCID: PMC4485936.
  20. Yu EW, Bouxsein ML, Putman MS, Monis EL, Roy AE, Pratt JS, Butsch WS, Finkelstein JS. Two-year changes in bone density after Roux-en-Y gastric bypass surgery. J Clin Endocrinol Metab. 2015 Apr; 100(4):1452-9. PMID: 25646793; PMCID: PMC4399296 [Available on 04/01/16].
  21. Solomon DH, Diem SJ, Ruppert K, Lian YJ, Liu CC, Wohlfart A, Greendale GA, Finkelstein JS. Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study. J Bone Miner Res. 2015 Feb; 30(2):232-9. PMID: 25156141; PMCID: PMC4404624.
  22. Putman MS, Bouxsein ML, Finkelstein JS. Response letter to the editor. J Clin Endocrinol Metab. 2015 Jan; 100(1):L9-L10. PMID: 25559548.
    View in: PubMed
  23. Dvorak MF, Noonan VK, Fallah N, Fisher CG, Finkelstein J, Kwon BK, Rivers CS, Ahn H, Paquet J, Tsai EC, Townson A, Attabib N, Bailey CS, Christie SD, Drew B, Fourney DR, Fox R, Hurlbert RJ, Johnson MG, Linassi AG, Parent S, Fehlings MG. The influence of time from injury to surgery on motor recovery and length of hospital stay in acute traumatic spinal cord injury: an observational Canadian cohort study. J Neurotrauma. 2015 May 01; 32(9):645-54. PMID: 25333195; PMCID: PMC4410758.
  24. Yu EW, Putman MS, Derrico N, Abrishamanian-Garcia G, Finkelstein JS, Bouxsein ML. Defects in cortical microarchitecture among African-American women with type 2 diabetes. Osteoporos Int. 2015 Feb; 26(2):673-9. PMID: 25398431; PMCID: PMC4400116.
  25. Rampersaud YR, Fisher C, Yee A, Dvorak MF, Finkelstein J, Wai E, Abraham E, Lewis SJ, Alexander D, Oxner W. Health-related quality of life following decompression compared to decompression and fusion for degenerative lumbar spondylolisthesis: a Canadian multicentre study. Can J Surg. 2014 Aug; 57(4):E126-33. PMID: 25078938; PMCID: PMC4119126.
  26. Putman MS, Milliren CE, Derrico N, Uluer A, Sicilian L, Lapey A, Sawicki G, Gordon CM, Bouxsein ML, Finkelstein JS. Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis. J Clin Endocrinol Metab. 2014 Sep; 99(9):3399-407. PMID: 24926955; PMCID: PMC4154107.
  27. Kaufmann M, Gallagher JC, Peacock M, Schlingmann KP, Konrad M, DeLuca HF, Sigueiro R, Lopez B, Mourino A, Maestro M, St-Arnaud R, Finkelstein JS, Cooper DP, Jones G. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab. 2014 Jul; 99(7):2567-74. PMID: 24670084; PMCID: PMC4079315.
  28. Uihlein AV, Finkelstein JS, Lee H, Leder BZ. FSH suppression does not affect bone turnover in eugonadal men. J Clin Endocrinol Metab. 2014 Jul; 99(7):2510-5. PMID: 24646101; PMCID: PMC4079307.
  29. Yu EW, Bouxsein ML, Roy AE, Baldwin C, Cange A, Neer RM, Kaplan LM, Finkelstein JS. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J Bone Miner Res. 2014 Mar; 29(3):542-50. PMID: 23929784; PMCID: PMC3918250.
  30. Fazeli PK, Wang IS, Miller KK, Herzog DB, Misra M, Lee H, Finkelstein JS, Bouxsein ML, Klibanski A. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab. 2014 Apr; 99(4):1322-9. PMID: 24456286; PMCID: PMC3973785.
  31. Finkelstein JS, Yu EW, Burnett-Bowie SA. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013 Dec 19; 369(25):2457. PMID: 24350954.
    View in: PubMed
  32. Putman MS, Yu EW, Lee H, Neer RM, Schindler E, Taylor AP, Cheston E, Bouxsein ML, Finkelstein JS. Differences in skeletal microarchitecture and strength in African-American and white women. J Bone Miner Res. 2013 Oct; 28(10):2177-85. PMID: 23572415; PMCID: PMC3779478.
  33. Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ, Leder BZ. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013 Sep 12; 369(11):1011-22. PMID: 24024838; PMCID: PMC4142768.
  34. Diem SJ, Ruppert K, Cauley JA, Lian Y, Bromberger JT, Finkelstein JS, Greendale GA, Solomon DH. Rates of bone loss among women initiating antidepressant medication use in midlife. J Clin Endocrinol Metab. 2013 Nov; 98(11):4355-63. PMID: 24001746; PMCID: PMC3816266.
  35. Sowers MR, Zheng H, Greendale GA, Neer RM, Cauley JA, Ellis J, Johnson S, Finkelstein JS. Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab. 2013 Jul; 98(7):2854-63. PMID: 23666961; PMCID: PMC3701268.
  36. Crandall CJ, Tseng CH, Karlamangla AS, Finkelstein JS, Randolph JF, Thurston RC, Huang MH, Zheng H, Greendale GA. Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period. J Clin Endocrinol Metab. 2013 Apr; 98(4):E654-63. PMID: 23443812; PMCID: PMC3615209.
  37. Mitchell DM, Henao MP, Finkelstein JS, Burnett-Bowie SA. Prevalence and predictors of vitamin D deficiency in healthy adults. Endocr Pract. 2012 Nov-Dec; 18(6):914-23. PMID: 22982792; PMCID: PMC3755751.
  38. Cauley JA, Danielson ME, Greendale GA, Finkelstein JS, Chang YF, Lo JC, Crandall CJ, Neer RM, Ruppert K, Meyn L, Prairie BA, Sowers MR. Bone resorption and fracture across the menopausal transition: the Study of Women's Health Across the Nation. Menopause. 2012 Nov; 19(11):1200-7. PMID: 22850443; PMCID: PMC3483443.
  39. Yu EW, Finkelstein JS. Bone density screening intervals for osteoporosis: one size does not fit all. JAMA. 2012 Jun 27; 307(24):2591-2. PMID: 22735425.
    View in: PubMed
  40. Wildman RP, Tepper PG, Crawford S, Finkelstein JS, Sutton-Tyrrell K, Thurston RC, Santoro N, Sternfeld B, Greendale GA. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2012 Sep; 97(9):E1695-704. PMID: 22723312; PMCID: PMC3431568.
  41. Adler RA, Finkelstein J. Patient guide to osteoporosis in men. J Clin Endocrinol Metab. 2012 Jun; 97(6):39A-40A. PMID: 22675070.
    View in: PubMed
  42. Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Jun; 97(6):1802-22. PMID: 22675062.
    View in: PubMed
  43. Burnett-Bowie SA, Leder BZ, Henao MP, Baldwin CM, Hayden DL, Finkelstein JS. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. Clin J Am Soc Nephrol. 2012 Apr; 7(4):624-31. PMID: 22300739; PMCID: PMC3315336.
  44. Yu EW, Thomas BJ, Brown JK, Finkelstein JS. Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. J Bone Miner Res. 2012 Jan; 27(1):119-24. PMID: 21915902; PMCID: PMC3864640.
  45. Greendale GA, Sowers M, Han W, Huang MH, Finkelstein JS, Crandall CJ, Lee JS, Karlamangla AS. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res. 2012 Jan; 27(1):111-8. PMID: 21976317; PMCID: PMC3378821.
  46. Esses SI, McGuire R, Jenkins J, Finkelstein J, Woodard E, Watters WC, Goldberg MJ, Keith M, Turkelson CM, Wies JL, Sluka P, Boyer KM, Hitchcock K, Raymond L. American Academy of Orthopaedic Surgeons clinical practice guideline on: the treatment of osteoporotic spinal compression fractures. J Bone Joint Surg Am. 2011 Oct 19; 93(20):1934-6. PMID: 22012531.
    View in: PubMed
  47. Lo JC, Burnett-Bowie SA, Finkelstein JS. Bone and the perimenopause. Obstet Gynecol Clin North Am. 2011 Sep; 38(3):503-17. PMID: 21961717; PMCID: PMC3920744.
  48. Smith MR, Zietman AL, Finkelstein JS, Wu CL. Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer. N Engl J Med. 2011 May 26; 364(21):2044-51. PMID: 21612474.
    View in: PubMed
  49. Yu EW, Neer RM, Lee H, Wyland JJ, de la Paz AV, Davis MC, Okazaki M, Finkelstein JS. Time-dependent changes in skeletal response to teriparatide: escalating vs. constant dose teriparatide (PTH 1-34) in osteoporotic women. Bone. 2011 Apr 01; 48(4):713-9. PMID: 21111078; PMCID: PMC3073572.
  50. Mitera G, Probyn L, Ford M, Donovan A, Rubenstein J, Finkelstein J, Christakis M, Zhang L, Campos S, Culleton S, Nguyen J, Sahgal A, Barnes E, Tsao M, Danjoux C, Holden L, Yee A, Khan L, Chow E. Correlation of computed tomography imaging features with pain response in patients with spine metastases after radiation therapy. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):827-30. PMID: 20889265.
    View in: PubMed
  51. Finkelstein JS, Wyland JJ, Lee H, Neer RM. Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis. J Clin Endocrinol Metab. 2010 Apr; 95(4):1838-45. PMID: 20164296; PMCID: PMC2853981.
  52. Solomon DH, Finkelstein JS, Shadick N, LeBoff MS, Winalski CS, Stedman M, Glass R, Brookhart MA, Weinblatt ME, Gravallese EM. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 2009 Jun; 60(6):1624-31. PMID: 19479876; PMCID: PMC2748798.
  53. Leder BZ, Neer RM, Wyland JJ, Lee HW, Burnett-Bowie SM, Finkelstein JS. Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis. J Clin Endocrinol Metab. 2009 Aug; 94(8):2915-21. PMID: 19435827; PMCID: PMC2730878.
  54. Finkelstein JS, Wyland JJ, Leder BZ, Burnett-Bowie SM, Lee H, Jüppner H, Neer RM. Effects of teriparatide retreatment in osteoporotic men and women. J Clin Endocrinol Metab. 2009 Jul; 94(7):2495-501. PMID: 19401368; PMCID: PMC2708954.
  55. Moore AF, Wexler TL, Yung RL, Kish J, Larvie M, Lauter K, Arnold A, Finkelstein JS, Burnett-Bowie SM. An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levels. Endocr Pract. 2008 Oct; 14(7):892-7. PMID: 18996820.
    View in: PubMed
  56. Smith MR, Lee H, McGovern F, Fallon MA, Goode M, Zietman AL, Finkelstein JS. Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome. Cancer. 2008 May 15; 112(10):2188-94. PMID: 18348297; PMCID: PMC2562782.
  57. Yee A, Adjei N, Do J, Ford M, Finkelstein J. Do patient expectations of spinal surgery relate to functional outcome? Clin Orthop Relat Res. 2008 May; 466(5):1154-61. PMID: 18347892; PMCID: PMC2311462.
  58. Polinski JM, Cadarette SM, Arnold M, Katz JN, Finkelstein JS, Brookhart MA, Canning C, Avorn J, Solomon DH. High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania. Int Q Community Health Educ. 2008-2009; 29(3):223-40. PMID: 19720587; PMCID: PMC2885851.
  59. Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, Lo JC, Johnston JM, Cauley JA, Danielson ME, Neer RM. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2008 Mar; 93(3):861-8. PMID: 18160467; PMCID: PMC2266953.
  60. Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA, Arnold M, Gauthier S, Avorn J. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res. 2007 Nov; 22(11):1808-15. PMID: 17645403.
    View in: PubMed
  61. Michaelson MD, Kaufman DS, Lee H, McGovern FJ, Kantoff PW, Fallon MA, Finkelstein JS, Smith MR. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. J Clin Oncol. 2007 Mar 20; 25(9):1038-42. PMID: 17369566; PMCID: PMC3047397.
  62. Brookhart MA, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Patrick AR, Mogun H, Solmon DH. Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med. 2007 Mar; 120(3):251-6. PMID: 17349448.
    View in: PubMed
  63. Yee AJ, Akens M, Yang BL, Finkelstein J, Zheng PS, Deng Z, Yang B. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res. 2007; 9(4):R47. PMID: 17662123; PMCID: PMC2206723.
  64. Kaplan L, Bronstein Y, Barzilay Y, Hasharoni A, Finkelstein J. Canal expansive laminoplasty in the management of cervical spondylotic myelopathy. Isr Med Assoc J. 2006 Aug; 8(8):548-52. PMID: 16958245.
    View in: PubMed
  65. Burnett SM, Gunawardene SC, Bringhurst FR, Jüppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006 Aug; 21(8):1187-96. PMID: 16869716.
    View in: PubMed
  66. Michaelson MD, Lee H, Kaufman DS, Kantoff PW, Finkelstein J, Smith MR. Annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: A randomized placebo-controlled trial. J Clin Oncol. 2006 Jun 20; 24(18_suppl):4515. PMID: 27951772.
    View in: PubMed
  67. Finkelstein JS, Leder BZ, Burnett SM, Wyland JJ, Lee H, de la Paz AV, Gibson K, Neer RM. Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. J Clin Endocrinol Metab. 2006 Aug; 91(8):2882-7. PMID: 16684825.
    View in: PubMed
  68. Ahn H, Mousavi P, Roth S, Reidy D, Finkelstein J, Whyne C. Stability of the metastatic spine pre and post vertebroplasty. J Spinal Disord Tech. 2006 May; 19(3):178-82. PMID: 16770214.
    View in: PubMed
  69. Finkelstein JS. Calcium plus vitamin D for postmenopausal women--bone appétit? N Engl J Med. 2006 Feb 16; 354(7):750-2. PMID: 16481643.
    View in: PubMed
  70. Cheung G, Chow E, Holden L, Vidmar M, Danjoux C, Yee AJ, Connolly R, Finkelstein J. Percutaneous vertebroplasty in patients with intractable pain from osteoporotic or metastatic fractures: A prospective study using quality-of-life assessment. Can Assoc Radiol J. 2006 Feb; 57(1):13-21. PMID: 16719207.
    View in: PubMed
  71. Solomon DH, Finkelstein JS, Polinski JM, Arnold M, Licari A, Cabral D, Canning C, Avorn J, Katz JN. A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporos Int. 2006; 17(5):760-7. PMID: 16432644.
    View in: PubMed
  72. Sowers MR, Jannausch M, McConnell D, Little R, Greendale GA, Finkelstein JS, Neer RM, Johnston J, Ettinger B. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab. 2006 Apr; 91(4):1261-7. PMID: 16403818.
    View in: PubMed
  73. Lee H, Finkelstein JS, Miller M, Comeaux SJ, Cohen RI, Leder BZ. Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men. J Clin Endocrinol Metab. 2006 Mar; 91(3):1069-75. PMID: 16352679.
    View in: PubMed
  74. Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA. Compliance with osteoporosis medications. Arch Intern Med. 2005 Nov 14; 165(20):2414-9. PMID: 16287772.
    View in: PubMed
  75. Lee H, McGovern K, Finkelstein JS, Smith MR. Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma. Cancer. 2005 Oct 15; 104(8):1633-7. PMID: 16116596.
    View in: PubMed
  76. Leder BZ, Finkelstein JS. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. Osteoporos Int. 2005 Dec; 16(12):1487-94. PMID: 15856361.
    View in: PubMed
  77. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, Korenman S, Lasley WL, Luborsky JL, McConnell D, Sowers MF, Weiss G. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab. 2005 Aug; 90(8):4836-45. PMID: 15840738.
    View in: PubMed
  78. Solomon DH, Finkelstein JS, Wang PS, Avorn J. Statin lipid-lowering drugs and bone mineral density. Pharmacoepidemiol Drug Saf. 2005 Apr; 14(4):219-26. PMID: 15386702.
    View in: PubMed
  79. Solomon DH, Morris C, Cheng H, Cabral D, Katz JN, Finkelstein JS, Avorn J. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005 Feb; 80(2):194-202. PMID: 15704774.
    View in: PubMed
  80. Bilezikian JP, Rubin MR, Finkelstein JS. Parathyroid hormone as an anabolic therapy for women and men. J Endocrinol Invest. 2005; 28(8 Suppl):41-9. PMID: 16329201.
    View in: PubMed
  81. Smith MR, Fallon MA, Lee H, Finkelstein JS. Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. J Clin Endocrinol Metab. 2004 Aug; 89(8):3841-6. PMID: 15292315.
    View in: PubMed
  82. Morris CA, Cabral D, Cheng H, Katz JN, Finkelstein JS, Avorn J, Solomon DH. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004 Jul; 19(7):783-90. PMID: 15209594; PMCID: PMC1492483.
  83. Smith MR, Goode M, Zietman AL, McGovern FJ, Lee H, Finkelstein JS. Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J Clin Oncol. 2004 Jul 01; 22(13):2546-53. PMID: 15226323.
    View in: PubMed
  84. Santoro N, Lasley B, McConnell D, Allsworth J, Crawford S, Gold EB, Finkelstein JS, Greendale GA, Kelsey J, Korenman S, Luborsky JL, Matthews K, Midgley R, Powell L, Sabatine J, Schocken M, Sowers MF, Weiss G. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab. 2004 Jun; 89(6):2622-31. PMID: 15181033.
    View in: PubMed
  85. Asthana S, Bhasin S, Butler RN, Fillit H, Finkelstein J, Harman SM, Holstein L, Korenman SG, Matsumoto AM, Morley JE, Tsitouras P, Urban R. Masculine vitality: pros and cons of testosterone in treating the andropause. J Gerontol A Biol Sci Med Sci. 2004 May; 59(5):461-5. PMID: 15123756.
    View in: PubMed
  86. Chow E, Holden L, Rubenstein J, Christakis M, Sixel K, Vidmar M, Finkelstein J, Hayter C, Loblaw A, Wong R, Szumacher E, Danjoux C. Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy--a feasibility study. Radiother Oncol. 2004 Mar; 70(3):291-4. PMID: 15064015.
    View in: PubMed
  87. Chow E, Holden L, Danjoux C, Yee A, Vidmar M, Connolly R, Finkelstein J, Cheung G. Successful salvage using percutaneous vertebroplasty in cancer patients with painful spinal metastases or osteoporotic compression fractures. Radiother Oncol. 2004 Mar; 70(3):265-7. PMID: 15064011.
    View in: PubMed
  88. Roth SE, Mousavi P, Finkelstein J, Chow E, Kreder H, Whyne CM. Metastatic burst fracture risk prediction using biomechanically based equations. Clin Orthop Relat Res. 2004 Feb; (419):83-90. PMID: 15021137.
    View in: PubMed
  89. Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003 Oct 01; 115(5):398-400. PMID: 14553876.
    View in: PubMed
  90. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med. 2003 Sep 25; 349(13):1216-26. PMID: 14500805.
    View in: PubMed
  91. Mousavi P, Roth S, Finkelstein J, Cheung G, Whyne C. Volumetric quantification of cement leakage following percutaneous vertebroplasty in metastatic and osteoporotic vertebrae. J Neurosurg. 2003 Jul; 99(1 Suppl):56-9. PMID: 12859060.
    View in: PubMed
  92. Sowers MR, Greendale GA, Bondarenko I, Finkelstein JS, Cauley JA, Neer RM, Ettinger B. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int. 2003 May; 14(3):191-7. PMID: 12730778.
    View in: PubMed
  93. Randolph JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab. 2003 Apr; 88(4):1516-22. PMID: 12679432.
    View in: PubMed
  94. Solomon DH, Connelly MT, Rosen CJ, Dawson-Hughes B, Kiel DP, Greenspan SL, Leib ES, Holick M, Miguel AH, Finkelstein JS. Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England. Osteoporos Int. 2003 Apr; 14(2):123-9. PMID: 12730780.
    View in: PubMed
  95. Greendale GA, Huang MH, Wang Y, Finkelstein JS, Danielson ME, Sternfeld B. Sport and home physical activity are independently associated with bone density. Med Sci Sports Exerc. 2003 Mar; 35(3):506-12. PMID: 12618583.
    View in: PubMed
  96. Sowers MR, Finkelstein JS, Ettinger B, Bondarenko I, Neer RM, Cauley JA, Sherman S, Greendale GA. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int. 2003 Jan; 14(1):44-52. PMID: 12577184.
    View in: PubMed
  97. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003 Jan; 88(1):204-10. PMID: 12519853.
    View in: PubMed
  98. Leder BZ, Leblanc KM, Longcope C, Lee H, Catlin DH, Finkelstein JS. Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women. J Clin Endocrinol Metab. 2002 Dec; 87(12):5449-54. PMID: 12466335.
    View in: PubMed
  99. Finkelstein JS, Lee ML, Sowers M, Ettinger B, Neer RM, Kelsey JL, Cauley JA, Huang MH, Greendale GA. Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002 Jul; 87(7):3057-67. PMID: 12107201.
    View in: PubMed
  100. Finkelstein JS, Sowers M, Greendale GA, Lee ML, Neer RM, Cauley JA, Ettinger B. Ethnic variation in bone turnover in pre- and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002 Jul; 87(7):3051-6. PMID: 12107200.
    View in: PubMed
  101. Catlin DH, Leder BZ, Ahrens BD, Hatton CK, Finkelstein JS. Effects of androstenedione administration on epitestosterone metabolism in men. Steroids. 2002 Jun; 67(7):559-64. PMID: 11996927.
    View in: PubMed
  102. Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, Schoenfeld DA, Kantoff PW. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab. 2002 Feb; 87(2):599-603. PMID: 11836291.
    View in: PubMed
  103. Smith MR, McGovern FJ, Zietman AL, Fallon MA, Hayden DL, Schoenfeld DA, Kantoff PW, Finkelstein JS. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med. 2001 Sep 27; 345(13):948-55. PMID: 11575286.
    View in: PubMed
  104. Leder BZ, Catlin DH, Longcope C, Ahrens B, Schoenfeld DA, Finkelstein JS. Metabolism of orally administered androstenedione in young men. J Clin Endocrinol Metab. 2001 Aug; 86(8):3654-8. PMID: 11502792.
    View in: PubMed
  105. Platt R, Davis R, Finkelstein J, Go AS, Gurwitz JH, Roblin D, Soumerai S, Ross-Degnan D, Andrade S, Goodman MJ, Martinson B, Raebel MA, Smith D, Ulcickas-Yood M, Chan KA. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf. 2001 Aug-Sep; 10(5):373-7. PMID: 11802579.
    View in: PubMed
  106. Smith MR, McGovern FJ, Fallon MA, Schoenfeld D, Kantoff PW, Finkelstein JS. Low bone mineral density in hormone-naïve men with prostate carcinoma. Cancer. 2001 Jun 15; 91(12):2238-45. PMID: 11413511.
    View in: PubMed
  107. Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab. 2001 May; 86(5):2020-6. PMID: 11344201.
    View in: PubMed
  108. Leder BZ, Smith MR, Fallon MA, Lee ML, Finkelstein JS. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men. J Clin Endocrinol Metab. 2001 Feb; 86(2):511-6. PMID: 11158001.
    View in: PubMed
  109. Catlin DH, Leder BZ, Ahrens B, Starcevic B, Hatton CK, Green GA, Finkelstein JS. Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. JAMA. 2000 Nov 22-29; 284(20):2618-21. PMID: 11086369.
    View in: PubMed
  110. Zmuda JM, Cauley JA, Glynn NW, Finkelstein JS. Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men. J Bone Miner Res. 2000 Jul; 15(7):1417-24. PMID: 10893693.
    View in: PubMed
  111. Leder BZ, Longcope C, Catlin DH, Ahrens B, Schoenfeld DA, Finkelstein JS. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA. 2000 Feb 09; 283(6):779-82. PMID: 10683057.
    View in: PubMed
  112. Finkelstein JS, Klibanski A, Neer RM. Evaluation of lumber spine bone mineral density (BMD) using dual energy x-ray absorptiometry (DXA) in 21 young men with histories of constitutionally-delayed puberty. J Clin Endocrinol Metab. 1999 Sep; 84(9):3400-1; author reply 3403-4. PMID: 10487720.
    View in: PubMed
  113. Goldstein LE, Sporn J, Brown S, Kim H, Finkelstein J, Gaffey GK, Sachs G, Stern TA. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics. 1999 Sep-Oct; 40(5):438-43. PMID: 10479950.
    View in: PubMed
  114. Finkelstein JS, Schoenfeld DA. Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women. J Clin Endocrinol Metab. 1999 Jun; 84(6):2151-6. PMID: 10372724.
    View in: PubMed
  115. Finkelstein JS, Arnold AL. Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis. J Clin Endocrinol Metab. 1999 Apr; 84(4):1214-9. PMID: 10199756.
    View in: PubMed
  116. Finkelstein JS, Klibanski A, Arnold AL, Toth TL, Hornstein MD, Neer RM. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. JAMA. 1998 Sep 23-30; 280(12):1067-73. PMID: 9757854.
    View in: PubMed
  117. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998 Mar 19; 338(12):777-83. PMID: 9504937.
    View in: PubMed
  118. Gibson KM, Christensen E, Jakobs C, Fowler B, Clarke MA, Hammersen G, Raab K, Kobori J, Moosa A, Vollmer B, Rossier E, Iafolla AK, Matern D, Brouwer OF, Finkelstein J, Aksu F, Weber HP, Bakkeren JA, Gabreels FJ, Bluestone D, Barron TF, Beauvais P, Rabier D, Santos C, Lehnert W, et al. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. Pediatrics. 1997 Apr; 99(4):567-74. PMID: 9093300.
    View in: PubMed
  119. Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med. 1996 Dec 01; 125(11):883-90. PMID: 8967668.
    View in: PubMed
  120. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996 Dec; 81(12):4358-65. PMID: 8954042.
    View in: PubMed
  121. Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab. 1996 Mar; 81(3):1152-5. PMID: 8772591.
    View in: PubMed
  122. Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med. 1994 Dec 15; 331(24):1618-23. PMID: 7969342.
    View in: PubMed
  123. Finkelstein JS, Butler JP, Cleary RL, Neer RM. Comparison of four methods for cross-calibrating dual-energy X-ray absorptiometers to eliminate systematic errors when upgrading equipment. J Bone Miner Res. 1994 Dec; 9(12):1945-52. PMID: 7872060.
    View in: PubMed
  124. Finkelstein JS, Cleary RL, Butler JP, Antonelli R, Mitlak BH, Deraska DJ, Zamora-Quezada JC, Neer RM. A comparison of lateral versus anterior-posterior spine dual energy x-ray absorptiometry for the diagnosis of osteopenia. J Clin Endocrinol Metab. 1994 Mar; 78(3):724-30. PMID: 8126149.
    View in: PubMed
  125. Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992 Feb 27; 326(9):600-4. PMID: 1734250.
    View in: PubMed
  126. Finkelstein JS, O'Dea LS, Whitcomb RW, Crowley WF. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 1991 Sep; 73(3):621-8. PMID: 1908485.
    View in: PubMed
  127. Finkelstein JS, Whitcomb RW, O'Dea LS, Longcope C, Schoenfeld DA, Crowley WF. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 1991 Sep; 73(3):609-20. PMID: 1908484.
    View in: PubMed
  128. Crowley WF, Whitcomb RW, Jameson JL, Weiss J, Finkelstein JS, O'Dea LS. Neuroendocrine control of human reproduction in the male. Recent Prog Horm Res. 1991; 47:27-62; discussion 62-7. PMID: 1745823.
    View in: PubMed
  129. Whitcomb RW, O'Dea LS, Finkelstein JS, Heavern DM, Crowley WF. Utility of free alpha-subunit as an alternative neuroendocrine marker of gonadotropin-releasing hormone (GnRH) stimulation of the gonadotroph in the human: evidence from normal and GnRH-deficient men. J Clin Endocrinol Metab. 1990 Jun; 70(6):1654-61. PMID: 1693373.
    View in: PubMed
  130. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley WF. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1989 Oct; 69(4):776-83. PMID: 2674186.
    View in: PubMed
  131. Finkelstein JS, Spratt DI, O'Dea LS, Whitcomb RW, Klibanski A, Schoenfeld DA, Crowley WF. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men. J Clin Endocrinol Metab. 1989 Aug; 69(2):377-85. PMID: 2502554.
    View in: PubMed
  132. O'Dea LS, Finkelstein JS, Schoenfeld DA, Butler JP, Crowley WF. Interpulse interval of GnRH stimulation independently modulates LH secretion. Am J Physiol. 1989 Apr; 256(4 Pt 1):E510-5. PMID: 2650563.
    View in: PubMed
  133. Grassi CJ, Bettmann MA, Finkelstein J, Reagan K. Ioversol. Double-blind study of a new low osmolar contrast agent for peripheral and visceral arteriography. Invest Radiol. 1989 Feb; 24(2):133-7. PMID: 2917833.
    View in: PubMed
  134. Finkelstein JS, Badger TM, O'Dea LS, Spratt DI, Crowley WF. Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells. J Clin Invest. 1988 Jun; 81(6):1725-33. PMID: 3290251; PMCID: PMC442617.
  135. Finkelstein JS, McCully WF, MacLaughlin DT, Godine JE, Crowley WF. The mortician's mystery. Gynecomastia and reversible hypogonadotropic hypogonadism in an embalmer. N Engl J Med. 1988 Apr 14; 318(15):961-5. PMID: 3352686.
    View in: PubMed
  136. Spratt DI, Finkelstein JS, Butler JP, Badger TM, Crowley WF. Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men. J Clin Endocrinol Metab. 1987 Jun; 64(6):1179-86. PMID: 3106396.
    View in: PubMed
  137. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987 Mar; 106(3):354-61. PMID: 3544993.
    View in: PubMed
  138. Spratt DI, Finkelstein JS, O'Dea LS, Badger TM, Rao PN, Campbell JD, Crowley WF. Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects. Ann Intern Med. 1986 Dec; 105(6):848-55. PMID: 3096182.
    View in: PubMed
  139. Spratt DI, Finkelstein JS, Badger TM, Butler JP, Crowley WF. Bio- and immunoactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): dose-response curves in GnRH-deficient men. J Clin Endocrinol Metab. 1986 Jul; 63(1):143-50. PMID: 3519645.
    View in: PubMed
  140. Campbell CS, Finkelstein JS, Turek FW. The interaction of photoperiod and testosterone on the development of copulatory behavior in castrated male hamsters. Physiol Behav. 1978 Sep; 21(3):409-15. PMID: 740757.
    View in: PubMed
  141. Finkelstein JS, Baum FR, Campbell CS. Entrainment of the female hamster to reversed photoperiod: role of the pineal. Physiol Behav. 1978 Jul; 21(1):105-11. PMID: 567813.
    View in: PubMed
  142. Boyar R, Finkelstein J, Roffwarg H, Kapen S, Weitzman E, Hellman L. Synchronization of augmented luteinizing hormone secretion with sleep during puberty. N Engl J Med. 1972 Sep 21; 287(12):582-6. PMID: 4341276.
    View in: PubMed
  143. Finkelstein J, Chiang E, Lee J. 2-Methyl-3-phenoxycyclopropylamine. J Med Chem. 1966 May; 9(3):440-1. PMID: 5960934.
    View in: PubMed
  144. Finkelstein J, Chiang E, Vane FM, Lee J. Synthesis of trans-2-cyclohexyloxycyclopropylamine and derivatives. J Med Chem. 1966 May; 9(3):319-23. PMID: 5960896.
    View in: PubMed
  145. Finkelstein J, Chiang E, Lee J. Synthesis of cis- and trans-2-phenoxycyclopropylamines and related compounds. J Med Chem. 1965 Jul; 8(4):432-9. PMID: 5884163.
    View in: PubMed
  146. FINKELSTEIN J, ROMANO JA, CHIANG E, LEE J. MONOAMINE OXIDASE INHIBITORS. IV. SOME DIALKYLAMINOPHENYLALKYLHYDRAZINES AND RELATED COMPOUNDS. J Med Chem. 1963 Mar; 6:153-5. PMID: 14188787.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Finkelstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_